Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.218
-0.012 (-0.97%)
At close: Nov 4, 2024, 4:00 PM
1.200
-0.018 (-1.49%)
After-hours: Nov 4, 2024, 4:40 PM EST

Dermata Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
4.957.446.2410.80.531.99
Cash & Short-Term Investments
4.957.446.2410.80.531.99
Cash Growth
-41.37%19.18%-42.20%1935.97%-73.37%-
Other Receivables
-0.010.01---
Receivables
-0.010.01---
Prepaid Expenses
0.150.440.60.770.080.07
Other Current Assets
0.140.090.090.06--
Total Current Assets
5.247.986.9411.620.612.07
Property, Plant & Equipment
-----0
Total Assets
5.247.986.9411.620.612.07
Accounts Payable
1.330.870.50.520.10.34
Accrued Expenses
0.590.760.4310.130.16
Short-Term Debt
----2.99-
Current Portion of Long-Term Debt
----0.560.73
Other Current Liabilities
-----0.5
Total Current Liabilities
1.921.620.921.523.781.72
Long-Term Debt
-----0.55
Total Liabilities
1.921.620.921.523.782.28
Common Stock
00002.352.35
Additional Paid-In Capital
62.6759.7451.6146.09--
Retained Earnings
-59.35-53.39-45.59-35.98-28.08-24.84
Total Common Equity
3.326.366.0210.11-25.73-22.49
Shareholders' Equity
3.326.366.0210.11-3.18-0.21
Total Liabilities & Equity
5.247.986.9411.620.612.07
Total Debt
----3.551.28
Net Cash (Debt)
4.957.446.2410.8-3.020.71
Net Cash Growth
-41.37%19.18%-42.20%---
Net Cash Per Share
11.9738.15135.55602.41--
Filing Date Shares Outstanding
1.320.440.050.0346.66-
Total Common Shares Outstanding
0.690.260.050.0346.66-
Working Capital
3.326.366.0210.11-3.180.34
Book Value Per Share
4.7924.25117.29291.25-0.55-
Tangible Book Value
3.326.366.0210.11-25.73-22.49
Tangible Book Value Per Share
4.7924.25117.29291.25-0.55-
Machinery
-----0.08
Source: S&P Capital IQ. Standard template. Financial Sources.